The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

ResMed Inc

NYSE: RMD
Last

(U.S.) $64.24

Today's change0.00 0.00%
Updated February 26 4:03 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $64.24

Today's change0.00 0.00%
Updated February 26 4:03 PM EST. Delayed by at least 15 minutes.

ResMed Inc closed at (U.S.)$64.24.

Shares have lost 1.41% over the last five days, but sit 4.83% below their 52-week high. This security has outperformed the S&P 500 by 32.21% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $64.24
  • High--
  • Low--
  • Bid / Ask(U.S.) $40.16 / (U.S.) $72.04
  • YTD % change+14.59%
  • Volume0
  • Average volume (10-day)544,943
  • Average volume (1-month)879,714
  • Average volume (3-month)1,084,320
  • 52-week range(U.S.) $42.19 to (U.S.) $67.50
  • Beta0.77
  • Trailing P/E26.06×
  • P/E 1 year forward24.64×
  • Forward PEG1.97×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield1.74%
  • Trailing EPS(U.S.) $2.47
Updated February 26 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.79%

Based on its net profit margin of 21.79%, ResMed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue423380415398
Total other revenue--------
Total revenue423380415398
Gross profit263237261252
Total cost of revenue160143154146
Total operating expense314286317293
Selling / general / administrative123111122115
Research & development29303230
Depreciation / amortization2222
Interest expense (income), net operating--------
Unusual expense (income)----6--
Other operating expenses, total--------
Operating income1099598105
Interest income (expense), net non-operating-----6--
Gain (loss) on sale of assets--------
Other--------
Income before tax116102107113
Income after tax91838890
Income tax, total24191923
Net income91838890
Total adjustments to net income--------
Net income before extra. items91838890
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items91838890
Inc. avail. to common incl. extra. items91838890
Diluted net income91838890
Dilution adjustment------0
Diluted weighted average shares142143143143
Diluted EPS excluding extraordinary itemsvalue per share0.640.580.610.63
Dividends per sharevalue per share0.280.280.250.25
Diluted normalized EPSvalue per share0.640.580.650.63